Author

Kevin L. Duffin

Eli Lilly (United States)ORCID 0000-0002-1656-8982Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:Bayesian inference· 1 Assay:bulk RNA-seq· 1 Research Focus:eQTL / molecular QTL mapping· 1 Research Focus:GWAS / association mapping· 1 Organism:human· 1 Assay:scATAC-seq· 1 Approach:statistical model· 1

Frequent Co-Authors

Adriana M. HungiD· 1 shared Benjamin F. VoightiD· 1 shared Chengxiang QiuiD· 1 shared Christopher D. BrowniD· 1 shared Hongbo LiuiD· 1 shared Jacklyn N. HellwegeiD· 1 shared Junnan WuiD· 1 shared Katalin SusztákiD· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenetics

Adriana M. HungORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments

Xin Sheng, Yuting Guan, Ziyuan Ma, Junnan Wu, Hongbo Liu, Chengxiang Qiu, Steven Vitale, Zhen Miao, Matthew J. Seasock, Matthew Palmer, Myung K. Shin, Kevin L. Duffin, Steven S. Pullen, Todd L. Edwards, Jacklyn N. Hellwege, , Katalin Suszták

The paper maps genetic variants to cell types in the kidney to identify disease mechanisms and drug targets.

Nature Genetics · Aug 12, 2021Peer-reviewedGenetics